Onyx Bridge Wealth Group LLC Gilead Sciences, Inc. Transaction History
Onyx Bridge Wealth Group LLC
- $684 Million
- Q2 2025
A detailed history of Onyx Bridge Wealth Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Onyx Bridge Wealth Group LLC holds 4,179 shares of GILD stock, worth $492,495. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,179
Previous 4,834
13.55%
Holding current value
$492,495
Previous $541,000
14.42%
% of portfolio
0.07%
Previous 0.08%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
2,328Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.98 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.46 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.42 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...